首页 > 最新文献

GE Portuguese Journal of Gastroenterology最新文献

英文 中文
Rifaximin as a Therapeutic Ally in the Modulation of Dysbiosis: A Narrative Review of Its Applicability in Gastrointestinal Disorders. 利福昔明作为调节生态失调的治疗盟友:对其在胃肠道疾病中的适用性的叙述综述。
IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-21 eCollection Date: 2025-12-01 DOI: 10.1159/000545926
Joana Frias, Miguel Martins, Armando Peixoto, Guilherme Macedo

Background: The gastrointestinal microbiota is vital for a well-functioning digestive tract, nutrient metabolism, immune support, and protection against pathogenic microorganisms. Disruption of this balance is known as dysbiosis. Rifaximin, an oral antibiotic with selective action, reduces harmful gut bacteria while preserving beneficial species, aiding in microbiota restoration.

Summary: Alterations in the intestinal microbiota are implicated in many gastrointestinal disorders. Rifaximin, by targeting and modulating the microbiota, may serve as a powerful tool in the approach of these conditions.

Key messages: This narrative review summarizes the main uses of rifaximin in gastrointestinal disorders like irritable bowel syndrome, diverticular disease, small intestinal bacterial overgrowth, traveler's diarrhea, hepatic encephalopathy, Clostridioides difficile infection, and inflammatory bowel disease.

背景:胃肠道微生物群对于消化道功能良好、营养代谢、免疫支持和对病原微生物的保护至关重要。这种平衡的破坏被称为生态失调。利福昔明是一种具有选择性作用的口服抗生素,可减少有害肠道细菌,同时保留有益物种,有助于微生物群的恢复。摘要:肠道菌群的改变与许多胃肠道疾病有关。利福昔明通过靶向和调节微生物群,可以作为治疗这些疾病的有力工具。本文综述了利福昔明在肠易激综合征、憩室病、小肠细菌过度生长、旅行者腹泻、肝性脑病、艰难梭菌感染和炎症性肠病等胃肠道疾病中的主要应用。
{"title":"Rifaximin as a Therapeutic Ally in the Modulation of Dysbiosis: A Narrative Review of Its Applicability in Gastrointestinal Disorders.","authors":"Joana Frias, Miguel Martins, Armando Peixoto, Guilherme Macedo","doi":"10.1159/000545926","DOIUrl":"10.1159/000545926","url":null,"abstract":"<p><strong>Background: </strong>The gastrointestinal microbiota is vital for a well-functioning digestive tract, nutrient metabolism, immune support, and protection against pathogenic microorganisms. Disruption of this balance is known as dysbiosis. Rifaximin, an oral antibiotic with selective action, reduces harmful gut bacteria while preserving beneficial species, aiding in microbiota restoration.</p><p><strong>Summary: </strong>Alterations in the intestinal microbiota are implicated in many gastrointestinal disorders. Rifaximin, by targeting and modulating the microbiota, may serve as a powerful tool in the approach of these conditions.</p><p><strong>Key messages: </strong>This narrative review summarizes the main uses of rifaximin in gastrointestinal disorders like irritable bowel syndrome, diverticular disease, small intestinal bacterial overgrowth, traveler's diarrhea, hepatic encephalopathy, <i>Clostridioides difficile</i> infection, and inflammatory bowel disease.</p>","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":" ","pages":"423-437"},"PeriodicalIF":0.6,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144318671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lactose Intolerance and Malabsorption Revisited: Exploring the Impact and Solutions. 重新审视乳糖不耐症和吸收不良:探索影响和解决方案。
IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-21 eCollection Date: 2025-10-01 DOI: 10.1159/000545923
Ana Isabel Borralho, Pedro Marcos

Background: Lactose intolerance (LI) is a condition in which the consumption of lactose-containing products leads to gastrointestinal symptoms. Despite being a common digestive disorder worldwide, LI is often overlooked, and there are few established recommendations for its diagnosis and management. This review aims to provide a comprehensive overview of LI, focusing on its clinical features, diagnostic evaluation, and management strategies.

Summary: A review of literature published from 2013 to 2023 on PubMed was conducted. Systematic reviews, meta-analyses, randomized controlled trials, case-control studies, cohort studies, and expert reviews were prioritized for analysis. LI is a common condition that shares symptoms with several other diseases. Various diagnostic tests are available to identify LI, including hydrogen breath test (HBT), lactose tolerance test, urinary galactose test, gaxilose test, rapid lactase test, and genetic testing. Managing LI may involve adopting a lactose-free or low-lactose diet, taking oral enzyme supplements, using probiotics and prebiotics, or consuming plant-based alternative beverages.

Key messages: LI affects many people worldwide and can significantly impact their quality of life. The HBT is the most widely used and effective method for diagnosing LI, along with a thorough assessment of symptoms. Instead of following a completely dairy-free diet, adopting a low-lactose diet - allowing up to 12-15 g of lactose per day - has been shown to be well tolerated and beneficial for most individuals with LI. While probiotics, prebiotics, and plant-based beverages may be helpful, their effectiveness in managing LI has not yet been proven.

背景:乳糖不耐症(LI)是指食用含乳糖产品导致胃肠道症状的一种情况。尽管LI是一种世界范围内常见的消化系统疾病,但它经常被忽视,并且很少有关于其诊断和管理的确定建议。本综述旨在提供LI的全面概述,重点是其临床特征,诊断评估和管理策略。摘要:对2013 - 2023年在PubMed上发表的文献进行综述。系统评价、荟萃分析、随机对照试验、病例对照研究、队列研究和专家评价被优先考虑。LI是一种常见的疾病,与其他几种疾病有相同的症状。有多种诊断测试可用于识别LI,包括氢呼气测试(HBT)、乳糖耐量测试、尿半乳糖测试、葡萄糖测试、快速乳糖酶测试和基因测试。管理LI可能包括采用无乳糖或低乳糖饮食,服用口服酶补充剂,使用益生菌和益生元,或饮用植物性替代饮料。关键信息:LI影响着全世界许多人,并能显著影响他们的生活质量。HBT是诊断LI最广泛使用和最有效的方法,同时还可以对症状进行全面评估。与完全不含乳制品的饮食相比,采用低乳糖饮食——每天允许12-15克乳糖——已被证明对大多数LI患者具有良好的耐受性和益处。虽然益生菌、益生元和植物性饮料可能有帮助,但它们在控制LI方面的有效性尚未得到证实。
{"title":"Lactose Intolerance and Malabsorption Revisited: Exploring the Impact and Solutions.","authors":"Ana Isabel Borralho, Pedro Marcos","doi":"10.1159/000545923","DOIUrl":"10.1159/000545923","url":null,"abstract":"<p><strong>Background: </strong>Lactose intolerance (LI) is a condition in which the consumption of lactose-containing products leads to gastrointestinal symptoms. Despite being a common digestive disorder worldwide, LI is often overlooked, and there are few established recommendations for its diagnosis and management. This review aims to provide a comprehensive overview of LI, focusing on its clinical features, diagnostic evaluation, and management strategies.</p><p><strong>Summary: </strong>A review of literature published from 2013 to 2023 on PubMed was conducted. Systematic reviews, meta-analyses, randomized controlled trials, case-control studies, cohort studies, and expert reviews were prioritized for analysis. LI is a common condition that shares symptoms with several other diseases. Various diagnostic tests are available to identify LI, including hydrogen breath test (HBT), lactose tolerance test, urinary galactose test, gaxilose test, rapid lactase test, and genetic testing. Managing LI may involve adopting a lactose-free or low-lactose diet, taking oral enzyme supplements, using probiotics and prebiotics, or consuming plant-based alternative beverages.</p><p><strong>Key messages: </strong>LI affects many people worldwide and can significantly impact their quality of life. The HBT is the most widely used and effective method for diagnosing LI, along with a thorough assessment of symptoms. Instead of following a completely dairy-free diet, adopting a low-lactose diet - allowing up to 12-15 g of lactose per day - has been shown to be well tolerated and beneficial for most individuals with LI. While probiotics, prebiotics, and plant-based beverages may be helpful, their effectiveness in managing LI has not yet been proven.</p>","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":" ","pages":"350-357"},"PeriodicalIF":0.6,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12105853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144163246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommendations for the Clinical Practice concerning the Use of Cholangiopancreatoscopy: Proceedings from a Consensus Meeting. 关于使用胆管胰脏镜检查的临床实践建议:共识会议记录。
IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-08 eCollection Date: 2025-10-01 DOI: 10.1159/000545718
Jorge Canena, Pedro Pereira, Tiago Bana E Costa, David Horta, Luís Carvalho Lourenço, Eduardo Rodrigues-Pinto, Isabel Tarrio, Ana Rita Franco, Tarcísio Araújo, Luís Lopes

After a consensus meeting including experts from all over the country (more than 6 years of experience, at least 50 procedures and their center perform more than 30 procedures/year), several recommendations were issued. Main recommendations: (1) Single-operator digital cholangioscopy is indicated in cases of undetermined biliary strictures (UBSs) in which visual inspection, with or without histology, may change the patient's approach. (Strong recommendation, moderate quality of evidence). (2) In a cholangioscopy for a stricture of unclear etiology, the optical assessment aspects should be recorded in a standardized report and, according to the endoscopist's visual impression, suggest a malignant or benign etiology. (Strong recommendation, high quality of evidence). (3) When using cholangioscopy regardless of the visual impression, biopsies of the stenosis should be taken (ideally in a number equal to or greater than 6 fragments). (Strong recommendation, moderate quality of evidence). (4) Cholangioscopy with biopsies has a high diagnostic accuracy in the evaluation of UBSs, with a technical success >98% and visual diagnosis with sensitivity/specificity >95%. However, it must be considered that the sensitivity of histological diagnosis is lower (around 70%). (Strong recommendation, high quality of evidence). (5) The single-operator cholangioscopy (SOC)-assisted lithotripsy is a safe procedure associated with high rates of success. (Strong recommendation, high quality of evidence). (6) SOC-assisted lithotripsy should be reserved for selected cases in which conventional techniques for the treatment of difficult biliary stones have failed. However, SOC-assisted lithotripsy should be used early in the treatment algorithm to avoid repeated procedures. (Strong recommendation, moderate quality of evidence). (7) Pancreatoscopy can allow the diagnosis of lesions suggestive of malignancy in the pancreatic duct of patients with intraductal papillary mucinous neoplasm of the main duct with high sensitivity and specificity. The groups of patients who benefit most from its use are those with a diffusely dilated duct with a diameter greater than 10 mm, and in whom sectional imaging methods and endoscopic ultrasound do not reveal focal lesions. (Weak recommendation, low quality of evidence). (8) The use of intraductal lithotripsy guided by pancreatoscopy in patients with lithiasis in the main pancreatic duct should be reserved for patients with pain and lithiasis greater than 5 mm that cannot be removed using conventional techniques. Patients with an excessively distal location in the tail or head may cause increased technical difficulty. (Low recommendation, low quality of evidence).

经过全国专家(6年以上经验,至少50例手术,中心每年执行30例以上)的共识会议,提出了若干建议。主要建议:(1)对于不明原因的胆道狭窄(ubs),无论有无组织学,目视检查都可能改变患者的入路,应采用单操作数字胆道镜检查。(强烈推荐,证据质量中等)。(2)对病因不明的狭窄进行胆管镜检查时,应将光学评估方面记录在标准化报告中,并根据内镜医师的视觉印象判断其病因是恶性还是良性。(强烈推荐,高质量的证据)。(3)不论视觉印象如何,在胆道镜检查时,均应对狭窄处进行活检(最好是6片或6片以上)。(强烈推荐,证据质量中等)。(4)胆管镜活检对ubs的诊断准确率较高,技术成功率>98%,视觉诊断灵敏度/特异性>95%。然而,必须考虑到组织学诊断的敏感性较低(约为70%)。(强烈推荐,高质量的证据)。(5)单操作胆管镜(SOC)辅助碎石是一种安全的手术,成功率高。(强烈推荐,高质量的证据)。(6) soc辅助碎石应保留用于传统技术治疗难治性胆结石失败的特定病例。然而,soc辅助碎石应在治疗方案的早期使用,以避免重复操作。(强烈推荐,证据质量中等)。(7)胰镜检查对主管乳头状黏液性肿瘤患者胰管内提示恶性病变的诊断具有较高的敏感性和特异性。使用该方法获益最多的患者是那些导管弥漫性扩张且直径大于10mm的患者,在这些患者中,断层成像方法和内窥镜超声不能显示局灶性病变。(弱推荐,证据质量低)。(8)对于主胰管结石患者,胰镜引导下的导管内碎石应保留给疼痛且结石大于5mm且常规技术无法取出的患者。尾部或头部位置过远的患者可能会增加技术难度。(低推荐,低证据质量)。
{"title":"Recommendations for the Clinical Practice concerning the Use of Cholangiopancreatoscopy: Proceedings from a Consensus Meeting.","authors":"Jorge Canena, Pedro Pereira, Tiago Bana E Costa, David Horta, Luís Carvalho Lourenço, Eduardo Rodrigues-Pinto, Isabel Tarrio, Ana Rita Franco, Tarcísio Araújo, Luís Lopes","doi":"10.1159/000545718","DOIUrl":"10.1159/000545718","url":null,"abstract":"<p><p>After a consensus meeting including experts from all over the country (more than 6 years of experience, at least 50 procedures and their center perform more than 30 procedures/year), several recommendations were issued. Main recommendations: (1) Single-operator digital cholangioscopy is indicated in cases of undetermined biliary strictures (UBSs) in which visual inspection, with or without histology, may change the patient's approach. (Strong recommendation, moderate quality of evidence). (2) In a cholangioscopy for a stricture of unclear etiology, the optical assessment aspects should be recorded in a standardized report and, according to the endoscopist's visual impression, suggest a malignant or benign etiology. (Strong recommendation, high quality of evidence). (3) When using cholangioscopy regardless of the visual impression, biopsies of the stenosis should be taken (ideally in a number equal to or greater than 6 fragments). (Strong recommendation, moderate quality of evidence). (4) Cholangioscopy with biopsies has a high diagnostic accuracy in the evaluation of UBSs, with a technical success >98% and visual diagnosis with sensitivity/specificity >95%. However, it must be considered that the sensitivity of histological diagnosis is lower (around 70%). (Strong recommendation, high quality of evidence). (5) The single-operator cholangioscopy (SOC)-assisted lithotripsy is a safe procedure associated with high rates of success. (Strong recommendation, high quality of evidence). (6) SOC-assisted lithotripsy should be reserved for selected cases in which conventional techniques for the treatment of difficult biliary stones have failed. However, SOC-assisted lithotripsy should be used early in the treatment algorithm to avoid repeated procedures. (Strong recommendation, moderate quality of evidence). (7) Pancreatoscopy can allow the diagnosis of lesions suggestive of malignancy in the pancreatic duct of patients with intraductal papillary mucinous neoplasm of the main duct with high sensitivity and specificity. The groups of patients who benefit most from its use are those with a diffusely dilated duct with a diameter greater than 10 mm, and in whom sectional imaging methods and endoscopic ultrasound do not reveal focal lesions. (Weak recommendation, low quality of evidence). (8) The use of intraductal lithotripsy guided by pancreatoscopy in patients with lithiasis in the main pancreatic duct should be reserved for patients with pain and lithiasis greater than 5 mm that cannot be removed using conventional techniques. Patients with an excessively distal location in the tail or head may cause increased technical difficulty. (Low recommendation, low quality of evidence).</p>","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":" ","pages":"358-378"},"PeriodicalIF":0.6,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12105857/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144163284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum. 勘误表。
IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-07 eCollection Date: 2025-10-01 DOI: 10.1159/000544848

[This corrects the article DOI: 10.1159/000537685.].

[这更正了文章DOI: 10.1159/000537685]。
{"title":"Erratum.","authors":"","doi":"10.1159/000544848","DOIUrl":"https://doi.org/10.1159/000544848","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1159/000537685.].</p>","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":"32 5","pages":"379-380"},"PeriodicalIF":0.6,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12517667/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Referral to Liver Transplant: A National Survey from Portugal. 转介肝移植:一项来自葡萄牙的全国调查。
IF 1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-03 DOI: 10.1159/000545593
Filipe S Cardoso, Mónica Sousa, Luís Bagulho, Milena Mendes, Élia Mateus, Helena Glória, Jorge Lamelas, Luís Bicho, Raquel Mega, João S Coelho, Rui Perdigoto, Hugo P Marques

Introduction: The referral of patients with cirrhosis to liver transplant (LT) is a multi-stage, complex process. There is a lack of data on potential challenges to this process. We aimed to characterize challenges faced by Portuguese referring clinicians.

Methods: This was a cross-sectional survey from Curry Cabral Hospital, Lisbon, Portugal. The survey was open for 90 days, from August to November 2024. The survey included 13 questions: characterization of participants with 5 questions and characterization of the process of referral to LT with 8 questions.

Results: Overall, 56 clinicians responded to the survey (response rate of 46.7%). Their median (IQR) age was 38.1 (33.2-42.1) years. Their level of training was specialist grade for 47 (83.9%) and fellow or intern grade for 9 (16.1%) individuals. The responders were from 21 different hospitals in Portugal; 8 (38.1%) provided tertiary care and 2 (9.5%) were LT centers. Among responders, there was heterogeneity regarding the following topics: referring criteria to LT, liver-related prognostic scores, contact channels with the LT center, tests and visits part of the LT workup. Many of them suggested the following improvements to develop national or regional referral criteria, to expedite communication with the LT team, to accelerate access to the tests or visits part of the LT workup, and to shorten the time to the first appointment with the LT team.

Conclusion: Portuguese clinicians identified several challenges and improvements to the referral of patients with cirrhosis to LT. These findings may inform future strategies to streamline the referral to LT.

肝硬化患者转介到肝移植(LT)是一个多阶段、复杂的过程。目前缺乏关于这一进程可能面临的挑战的数据。我们旨在描述葡萄牙转诊临床医生面临的挑战。方法:这是一项来自葡萄牙里斯本Curry Cabral医院的横断面调查。该调查从2024年8月到11月为期90天。调查包括13个问题:5个问题是参与者的特征,8个问题是转诊到LT的过程的特征。结果:总体而言,56名临床医生回应了调查(有效率为46.7%)。他们的中位(IQR)年龄为38.1(33.2-42.1)岁。他们的培训水平为专家级47人(83.9%),研究员或实习生级9人(16.1%)。应答者来自葡萄牙21家不同的医院;8家(38.1%)提供三级保健,2家(9.5%)为LT中心。在应答者中,在以下主题上存在异质性:肝移植的参考标准、肝脏相关预后评分、与肝移植中心的联系渠道、肝移植检查和访视部分。他们中的许多人建议采取以下改进措施,以制定国家或区域转诊标准,加快与再诊小组的沟通,加快获得再诊小组检查或访问部分的机会,并缩短与再诊小组首次预约的时间。结论:葡萄牙临床医生确定了肝硬化患者转诊到肝移植的几个挑战和改进。这些发现可能为未来简化肝移植转诊的策略提供信息。
{"title":"Referral to Liver Transplant: A National Survey from Portugal.","authors":"Filipe S Cardoso, Mónica Sousa, Luís Bagulho, Milena Mendes, Élia Mateus, Helena Glória, Jorge Lamelas, Luís Bicho, Raquel Mega, João S Coelho, Rui Perdigoto, Hugo P Marques","doi":"10.1159/000545593","DOIUrl":"10.1159/000545593","url":null,"abstract":"<p><strong>Introduction: </strong>The referral of patients with cirrhosis to liver transplant (LT) is a multi-stage, complex process. There is a lack of data on potential challenges to this process. We aimed to characterize challenges faced by Portuguese referring clinicians.</p><p><strong>Methods: </strong>This was a cross-sectional survey from Curry Cabral Hospital, Lisbon, Portugal. The survey was open for 90 days, from August to November 2024. The survey included 13 questions: characterization of participants with 5 questions and characterization of the process of referral to LT with 8 questions.</p><p><strong>Results: </strong>Overall, 56 clinicians responded to the survey (response rate of 46.7%). Their median (IQR) age was 38.1 (33.2-42.1) years. Their level of training was specialist grade for 47 (83.9%) and fellow or intern grade for 9 (16.1%) individuals. The responders were from 21 different hospitals in Portugal; 8 (38.1%) provided tertiary care and 2 (9.5%) were LT centers. Among responders, there was heterogeneity regarding the following topics: referring criteria to LT, liver-related prognostic scores, contact channels with the LT center, tests and visits part of the LT workup. Many of them suggested the following improvements to develop national or regional referral criteria, to expedite communication with the LT team, to accelerate access to the tests or visits part of the LT workup, and to shorten the time to the first appointment with the LT team.</p><p><strong>Conclusion: </strong>Portuguese clinicians identified several challenges and improvements to the referral of patients with cirrhosis to LT. These findings may inform future strategies to streamline the referral to LT.</p>","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":" ","pages":"1-8"},"PeriodicalIF":1.0,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068880/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143998933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual Portal Hypertension in Hepatic Tuberculosis: A Case Report. 肝结核双门静脉高压症1例。
IF 1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-29 DOI: 10.1159/000545522
Amal Joseph, Prajob Geevarghese Prasad, Jeby Jacob, Harikumar Nair

Background: Hepatic tuberculosis in itself is a rare condition, and that causing portal hypertension is even rarer. We present a unique clinical scenario of portal hypertension in a 64-year-old woman, with tuberculosis causing both sinusoidal and prehepatic portal hypertension.

Case presentation: A 64-year-old woman presented with esophageal variceal bleeding. Evaluation revealed a rare combination of sinusoidal portal hypertension from hepatic tuberculosis and a prehepatic component of portal hypertension due to tubercular periportal lymphadenopathy compressing the portal vein at the hilum. Hepatic venous pressure gradient was 7 mm Hg, indicative of sinusoidal portal hypertension. Liver biopsy demonstrated bridging fibrosis and hepatic granulomas accounting for the sinusoidal component of portal hypertension. Since clinically significant portal hypertension is more than 10 mm Hg, variceal bleeding resulted from the additional element of prehepatic portal hypertension contributed by compression of extrahepatic portal vein by periportal lymph nodes. Positive tuberculosis polymerase chain reaction from lymph nodes confirmed the diagnosis and initiation of antitubercular therapy (ATT) led to significant clinical and biochemical improvement. This case represents a novel occurrence; hepatic tuberculosis causing both intrahepatic and prehepatic components of portal hypertension has not been reported in the literature.

Conclusion: This case sheds light on the rarity of hepatic tuberculosis causing portal hypertension and also the importance of considering this diagnosis in patients with atypical presentations of tuberculosis. Recognizing and treating this unique complication promptly with ATT can lead to favorable clinical outcomes.

背景:肝结核本身是一种罕见的疾病,而引起门静脉高压症更是罕见。我们提出一个独特的临床方案门静脉高压症在一个64岁的妇女,结核引起的窦性和肝前门静脉高压症。病例介绍:一名64岁女性,因食道静脉曲张出血。评估显示罕见的合并由肝结核引起的窦状门脉高压和由结核性门静脉周围淋巴结病压迫门静脉门静脉而引起的门静脉高压的肝前成分。肝静脉压梯度为7 mm Hg,提示门静脉窦性高压。肝活检显示桥性纤维化和肝肉芽肿是门静脉高压症的窦性成分。由于临床上明显的门静脉高压超过10毫米汞柱,静脉曲张出血是由门静脉周围淋巴结压迫肝外门静脉造成的肝前门静脉高压的附加因素引起的。淋巴结结核聚合酶链反应阳性证实了诊断和开始抗结核治疗(ATT)导致显着的临床和生化改善。这个案例是一个新事件;肝结核引起的门脉高压的肝内和肝前成分尚未在文献中报道。结论:本病例揭示了肝结核引起门静脉高压症的罕见性,以及在非典型结核患者中考虑这一诊断的重要性。及时认识和治疗这种独特的并发症可以导致良好的临床结果。
{"title":"Dual Portal Hypertension in Hepatic Tuberculosis: A Case Report.","authors":"Amal Joseph, Prajob Geevarghese Prasad, Jeby Jacob, Harikumar Nair","doi":"10.1159/000545522","DOIUrl":"10.1159/000545522","url":null,"abstract":"<p><strong>Background: </strong>Hepatic tuberculosis in itself is a rare condition, and that causing portal hypertension is even rarer. We present a unique clinical scenario of portal hypertension in a 64-year-old woman, with tuberculosis causing both sinusoidal and prehepatic portal hypertension.</p><p><strong>Case presentation: </strong>A 64-year-old woman presented with esophageal variceal bleeding. Evaluation revealed a rare combination of sinusoidal portal hypertension from hepatic tuberculosis and a prehepatic component of portal hypertension due to tubercular periportal lymphadenopathy compressing the portal vein at the hilum. Hepatic venous pressure gradient was 7 mm Hg, indicative of sinusoidal portal hypertension. Liver biopsy demonstrated bridging fibrosis and hepatic granulomas accounting for the sinusoidal component of portal hypertension. Since clinically significant portal hypertension is more than 10 mm Hg, variceal bleeding resulted from the additional element of prehepatic portal hypertension contributed by compression of extrahepatic portal vein by periportal lymph nodes. Positive tuberculosis polymerase chain reaction from lymph nodes confirmed the diagnosis and initiation of antitubercular therapy (ATT) led to significant clinical and biochemical improvement. This case represents a novel occurrence; hepatic tuberculosis causing both intrahepatic and prehepatic components of portal hypertension has not been reported in the literature.</p><p><strong>Conclusion: </strong>This case sheds light on the rarity of hepatic tuberculosis causing portal hypertension and also the importance of considering this diagnosis in patients with atypical presentations of tuberculosis. Recognizing and treating this unique complication promptly with ATT can lead to favorable clinical outcomes.</p>","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":" ","pages":"1-4"},"PeriodicalIF":1.0,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068881/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144032197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare Rectal Tumour: How to Approach It? 罕见的直肠肿瘤:如何处理?
IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-29 eCollection Date: 2025-12-01 DOI: 10.1159/000545592
Margarida Rajão Saraiva, Daniel Conceição, Ricardo Fonseca, Isadora Rosa
{"title":"Rare Rectal Tumour: How to Approach It?","authors":"Margarida Rajão Saraiva, Daniel Conceição, Ricardo Fonseca, Isadora Rosa","doi":"10.1159/000545592","DOIUrl":"10.1159/000545592","url":null,"abstract":"","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":" ","pages":"381-383"},"PeriodicalIF":0.6,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12058122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143995426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Celiac Crisis in the Postpartum: A Life-Threatening Cause of Diarrhea and Malnutrition. 产后乳糜泻危机:腹泻和营养不良的威胁生命的原因。
IF 1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-29 DOI: 10.1159/000545520
Madalena Pestana, Nélia Abreu, Vitor Magno Pereira, Paulo Câmara, Henrique Morna

Introduction: Celiac crisis is a rare, severe manifestation of celiac disease, characterized by acute gastrointestinal symptoms, malnutrition, metabolic disturbances, and potential life-threatening complications. Postpartum celiac crisis is particularly rare but can be triggered by the physiological and hormonal changes of the puerperal period.

Case presentation: We report the case of a 42-year-old woman with a 3-month history of watery diarrhea, significant weight loss, extremity paresthesias, muscle spasms, and lower limb edema following childbirth. Initial evaluation revealed severe malnutrition, electrolyte imbalances, and hypoalbuminemia. Endoscopic studies showed significant villous atrophy and mucosal damage, suggestive of celiac disease, which was confirmed by serological and histological findings. The patient was diagnosed with celiac crisis and initiated on a strict gluten-free diet with supportive care, resulting in full clinical and biochemical recovery.

Discussion: This case highlights the importance of considering CD in the differential diagnosis of postpartum malnutrition and chronic diarrhea. Postpartum period may trigger the disease, underscoring the need for awareness in clinical settings. Celiac hepatitis is a prevalent occurrence within the spectrum of CD, with transient transaminase elevation with resolution following the initiation of a gluten-free diet. Celiac crisis, though rare, requires prompt diagnosis and intervention to avoid further complications.

简介:乳糜泻危象是一种罕见的、严重的乳糜泻表现,其特点是急性胃肠道症状、营养不良、代谢紊乱和潜在的危及生命的并发症。产后乳糜泻危机特别罕见,但可由产褥期的生理和激素变化引发。病例介绍:我们报告一例42岁女性,分娩后出现水样腹泻、体重明显减轻、四肢感觉异常、肌肉痉挛和下肢水肿3个月的病史。初步评估显示严重营养不良、电解质失衡和低白蛋白血症。内窥镜检查显示明显的绒毛萎缩和粘膜损伤,提示乳糜泻,血清学和组织学结果证实了这一点。患者被诊断为乳糜泻危象,并开始严格的无麸质饮食和支持性护理,导致临床和生化完全恢复。讨论:本病例强调了产后营养不良和慢性腹泻鉴别诊断中考虑乳糜泻的重要性。产后时期可能引发疾病,强调需要在临床设置的认识。乳糜泻肝炎在乳糜泻谱系中是一种常见的疾病,在开始无麸质饮食后,转氨酶会短暂升高。乳糜泻虽然罕见,但需要及时诊断和干预,以避免进一步的并发症。
{"title":"Celiac Crisis in the Postpartum: A Life-Threatening Cause of Diarrhea and Malnutrition.","authors":"Madalena Pestana, Nélia Abreu, Vitor Magno Pereira, Paulo Câmara, Henrique Morna","doi":"10.1159/000545520","DOIUrl":"https://doi.org/10.1159/000545520","url":null,"abstract":"<p><strong>Introduction: </strong>Celiac crisis is a rare, severe manifestation of celiac disease, characterized by acute gastrointestinal symptoms, malnutrition, metabolic disturbances, and potential life-threatening complications. Postpartum celiac crisis is particularly rare but can be triggered by the physiological and hormonal changes of the puerperal period.</p><p><strong>Case presentation: </strong>We report the case of a 42-year-old woman with a 3-month history of watery diarrhea, significant weight loss, extremity paresthesias, muscle spasms, and lower limb edema following childbirth. Initial evaluation revealed severe malnutrition, electrolyte imbalances, and hypoalbuminemia. Endoscopic studies showed significant villous atrophy and mucosal damage, suggestive of celiac disease, which was confirmed by serological and histological findings. The patient was diagnosed with celiac crisis and initiated on a strict gluten-free diet with supportive care, resulting in full clinical and biochemical recovery.</p><p><strong>Discussion: </strong>This case highlights the importance of considering CD in the differential diagnosis of postpartum malnutrition and chronic diarrhea. Postpartum period may trigger the disease, underscoring the need for awareness in clinical settings. Celiac hepatitis is a prevalent occurrence within the spectrum of CD, with transient transaminase elevation with resolution following the initiation of a gluten-free diet. Celiac crisis, though rare, requires prompt diagnosis and intervention to avoid further complications.</p>","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":" ","pages":"1-8"},"PeriodicalIF":1.0,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12052340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144025255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Treatment of Early Rectal Cancer after Multiple Surgical Approaches: Endoscopic Intermuscular Dissection to the Rescue. 多种手术入路后早期直肠癌的内镜治疗:内窥镜下肌间夹层的抢救。
IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-27 eCollection Date: 2025-10-01 DOI: 10.1159/000544834
Pedro André Lima, Raquel R Mendes, Pedro Barreiro, Rui Mendo, Cristina Chagas
{"title":"Endoscopic Treatment of Early Rectal Cancer after Multiple Surgical Approaches: Endoscopic Intermuscular Dissection to the Rescue.","authors":"Pedro André Lima, Raquel R Mendes, Pedro Barreiro, Rui Mendo, Cristina Chagas","doi":"10.1159/000544834","DOIUrl":"10.1159/000544834","url":null,"abstract":"","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":"32 5","pages":"303-305"},"PeriodicalIF":0.6,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12517670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling a Rare Cause of Dysphagia. 揭示罕见的吞咽困难的原因。
IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-11 eCollection Date: 2025-12-01 DOI: 10.1159/000544073
Ana Rita Graça, Luís Santos, Marta Gravito-Soares, Elisa Gravito-Soares, João Martins Gama, Pedro Narra Figueiredo

Introduction: Malignant melanoma of the esophagus is an uncommon cause of dysphagia and accounts for only 0.1-0.2% of esophageal neoplasms. Diagnosis is based on esophagogastroduodenoscopy (EGD) with biopsies and immunohistochemical analysis, the latter being crucial in the amelanocytic variant. Gastrointestinal melanomas are more invasive and comprise poorer prognosis than cutaneous melanomas.

Case presentation: The authors present the case of a 70-year-old woman admitted to the emergency department for progressive dysphagia with 2 months of evolution. EGD revealed the presence of an extensive, eccentric lesion, occupying approximately half of the luminal circumference at the level of the distal esophagus with circumferential involvement of the esophagogastric junction and cardia. Thoracoabdominopelvic computed tomography and positron emission tomography showed signs of advanced disease. The initial endoscopic biopsies were inconclusive, and EGD was repeated with multiple biopsies directed at the most infiltrative areas, whose histopathological analysis with immunohistochemistry revealed neoplastic cells with marked nuclear positivity for SOX10 and cytoplasmic positivity for vimentin, Melan-A, and HMB45 with absence of melanin pigment, findings suggestive of esophagocardiac amelanocytic malignant melanoma. In a multidisciplinary team meeting, the neoplasm was deemed unresectable, and the proposal was for esophageal stent placement and palliative hormone therapy.

Discussion: Primary amelanocytic malignant melanoma is an exceptionally rare neoplasm and an extremely uncommon cause of dysphagia. In this context, we present a compelling case study that underscores the rarity of this histological type, the importance of directing biopsies to the most suspicious areas of the lesion to increase diagnostic yield, the need for a high clinical suspicion, and the atypical endoscopic presentation associated with the amelanocytic subtype.

食道恶性黑色素瘤是一种罕见的导致吞咽困难的原因,仅占食道肿瘤的0.1-0.2%。诊断基于食管胃十二指肠镜(EGD)活检和免疫组织化学分析,后者在无色素细胞变异中至关重要。胃肠道黑色素瘤比皮肤黑色素瘤侵袭性更强,预后更差。病例介绍:作者报告了一名70岁妇女因进展性吞咽困难2个月的进展而被急诊室收治的病例。EGD显示存在广泛的偏心病变,约占食管远端管腔周长的一半,并向周向累及食管胃交界处和贲门。胸腹骨盆计算机断层扫描和正电子发射断层扫描显示疾病进展的迹象。最初的内镜活检不确定,并在浸润性最严重的区域进行多次活检,重复EGD,免疫组织化学组织病理学分析显示肿瘤细胞SOX10核阳性,vimentin、Melan-A和HMB45细胞质阳性,缺乏黑色素,提示食管心脏无色素细胞性恶性黑色素瘤。在一个多学科小组会议上,肿瘤被认为是不可切除的,建议食管支架置入和姑息性激素治疗。讨论:原发性无色素细胞恶性黑色素瘤是一种非常罕见的肿瘤,也是引起吞咽困难的罕见原因。在这种情况下,我们提出了一个引人注目的病例研究,强调了这种组织学类型的罕见性,指导活检到病变最可疑区域以提高诊断率的重要性,需要高度的临床怀疑,以及与无釉细胞亚型相关的非典型内镜表现。
{"title":"Unveiling a Rare Cause of Dysphagia.","authors":"Ana Rita Graça, Luís Santos, Marta Gravito-Soares, Elisa Gravito-Soares, João Martins Gama, Pedro Narra Figueiredo","doi":"10.1159/000544073","DOIUrl":"10.1159/000544073","url":null,"abstract":"<p><strong>Introduction: </strong>Malignant melanoma of the esophagus is an uncommon cause of dysphagia and accounts for only 0.1-0.2% of esophageal neoplasms. Diagnosis is based on esophagogastroduodenoscopy (EGD) with biopsies and immunohistochemical analysis, the latter being crucial in the amelanocytic variant. Gastrointestinal melanomas are more invasive and comprise poorer prognosis than cutaneous melanomas.</p><p><strong>Case presentation: </strong>The authors present the case of a 70-year-old woman admitted to the emergency department for progressive dysphagia with 2 months of evolution. EGD revealed the presence of an extensive, eccentric lesion, occupying approximately half of the luminal circumference at the level of the distal esophagus with circumferential involvement of the esophagogastric junction and cardia. Thoracoabdominopelvic computed tomography and positron emission tomography showed signs of advanced disease. The initial endoscopic biopsies were inconclusive, and EGD was repeated with multiple biopsies directed at the most infiltrative areas, whose histopathological analysis with immunohistochemistry revealed neoplastic cells with marked nuclear positivity for SOX10 and cytoplasmic positivity for vimentin, Melan-A, and HMB45 with absence of melanin pigment, findings suggestive of esophagocardiac amelanocytic malignant melanoma. In a multidisciplinary team meeting, the neoplasm was deemed unresectable, and the proposal was for esophageal stent placement and palliative hormone therapy.</p><p><strong>Discussion: </strong>Primary amelanocytic malignant melanoma is an exceptionally rare neoplasm and an extremely uncommon cause of dysphagia. In this context, we present a compelling case study that underscores the rarity of this histological type, the importance of directing biopsies to the most suspicious areas of the lesion to increase diagnostic yield, the need for a high clinical suspicion, and the atypical endoscopic presentation associated with the amelanocytic subtype.</p>","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":"32 6","pages":"396-403"},"PeriodicalIF":0.6,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12705097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145769892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
GE Portuguese Journal of Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1